TY - JOUR
T1 - Delineation of the minimal encephalitogenic epitope of proteolipid protein peptide91-110 and critical residues required for induction of EAE in HLA-DR3 transgenic mice
AU - Mangalam, Ashutosh K.
AU - Khare, Meenakshi
AU - Krco, Christopher J.
AU - Rodriguez, Moses
AU - David, Chella S.
N1 - Funding Information:
The HLA transgenic mice were produced with support from NIH grant AI-14764. This work was funded by the National Institutes of Health grants P01-NS38468.
PY - 2005/4
Y1 - 2005/4
N2 - Previously, we have reported that proteolipid protein (PLP) peptide 91-110 can induce experimental autoimmune encephalomyelitis (EAE) in HLA-DR3 transgenic (tg) mice. Here we, report that residues spanning 97-108 are the minimal epitope required for induction of EAE in DR3 mice. Utilizing a series of alanine-substituted peptides, positions 99, 101, 102, 103, 104, and 106 are identified as residues necessary for an immune response. Further analysis indicated that amino acid isoleucine (99), aspartate (102) and lysine (104) are anchor residues facilitating binding to HLA-DR3 molecules. These results may have applications in the future design of peptide based immunotherapy.
AB - Previously, we have reported that proteolipid protein (PLP) peptide 91-110 can induce experimental autoimmune encephalomyelitis (EAE) in HLA-DR3 transgenic (tg) mice. Here we, report that residues spanning 97-108 are the minimal epitope required for induction of EAE in DR3 mice. Utilizing a series of alanine-substituted peptides, positions 99, 101, 102, 103, 104, and 106 are identified as residues necessary for an immune response. Further analysis indicated that amino acid isoleucine (99), aspartate (102) and lysine (104) are anchor residues facilitating binding to HLA-DR3 molecules. These results may have applications in the future design of peptide based immunotherapy.
KW - EAE/MS
KW - Epitopes
KW - MHC
KW - Proteolipid protein (PLP)
KW - Transgenic mice
UR - http://www.scopus.com/inward/record.url?scp=14844290264&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=14844290264&partnerID=8YFLogxK
U2 - 10.1016/j.jneuroim.2004.12.012
DO - 10.1016/j.jneuroim.2004.12.012
M3 - Article
C2 - 15748942
AN - SCOPUS:14844290264
SN - 0165-5728
VL - 161
SP - 40
EP - 48
JO - Journal of neuroimmunology
JF - Journal of neuroimmunology
IS - 1-2
ER -